Children's participation in health matters has been demonstrated to increase internal locus of control and decision-making ability (Tiffenberg 2000) , promote preparedness (Coyne 2011), decrease fears and concerns (Runeson 2002) , increase adherence (De Winter 2002) , reduce healthcare use (McPherson 2006) and promote satisfaction with health care (Alderson 2006; Freed 1998) . Lack of involvement can have adverse consequences such as increased fears and anxieties, reduced self esteem, depersonalisation, and feeling unprepared for procedures (Coyne 2006) . Children who are not involved may assume their views are unimportant or irrelevant and may not seek to share their views in future (Coyne 2010) . Therefore key documents emphasise the importance of children's participation in decision-making at a level commensurate with their experience, age, and abilities (Boylan 2004; Cavet 2005; Spinetta 2003) .There is strong support from policy makers for children's shared decision-making (SDM) but weak evidence about children's participation in SDM as this area of research is young and underdeveloped.
Childhood cancers
This review focused on SDM for children with cancer. There are 12 major types of childhood cancer but leukaemias (blood cell cancers) and cancers of the brain and central nervous system account for more than half of the new cases diagnosed. The most common type of leukaemia is acute lymphoblastic leukaemia. The most common tumours are brain tumours (for example gliomas and medulloblastomas). The other solid tumours are less common (for example neuroblastomas, Wilms' tumours, rhabdomyosarcoma, and osteosarcoma). With significant medical advances in recent years, increasingly, children are surviving cancer. Survival rates vary greatly according to the type of childhood cancer diagnosed. The mean five-year survival rate for all of the major childhood cancers among children aged under 15 years is now approximately 80% for those diagnosed in 1996 diagnosed in to 2004 diagnosed in (Jemal 2009 ).
Information sharing and decision-making
Cancer is a potentially life-threatening illness where important decisions are made at key points in the disease process. In many cases, several treatment options exist with different possible outcomes and substantial uncertainty. It is important for children's psychological welfare that they are allowed a collaborative role in decision-making. Children with cancer generally prefer to be involved in decision-making (Stegenga 2008; Zwaanswijk 2007) and consider it important that they have the opportunity to take part in the decisions concerning their health care, even in end-oflife decisions (Hinds 2001 ). It appears that children with cancer cope better with their illness when provided with developmentally appropriate information at different stages of the illness trajectory (Ishibashi 2001; Last 1996) . The International Society of Paediatric Oncology (SIOP) encourages doctors to share with children developmentally relevant information that will improve their ability to participate in the decision-making process (Spinetta 2003) . Information sharing is a prerequisite to SDM (Tates 2002a) but communication with children about their disease, treatment and care provision is often poorly performed in practice (Scott 2003) .
Participation in shared decision-making (SDM)
Parents and health professionals play an important role in communication interactions and can either facilitate or obstruct children's participation in decision-making. Although SDM is increasingly valued, children's participation is often limited. Research in primary care settings has revealed a variety of ways in which doctors and parents frequently constrain children's participation in triadic interactions (Moore 2006; Tates 2002b) . Research with adolescents with cancer found that they struggle to assert their independence in decision-making and dislike being controlled by their parents (Dunsmore 1995) . Participation in decision-making in childhood cancer is especially problematic because the management of the three-way relationship (parent, child, health professional) is complicated by issues of development and instincts for protection on the part of the adults involved (Dixon-Woods 2002; Young 2003) . There is currently no review of SDM interventions for children with cancer. However, there are three related systematic reviews that contribute useful background information. Moore 2004 assessed whether communication skills training is effective in changing health professionals' behaviour in cancer care with regard to communication and interaction with patients. Based on three trials, they concluded that labour-intensive communication skills training can have a beneficial effect on behaviour change in professionals working with people with cancer. Ranmal 2008 updated the Scott 2003 review of the effectiveness of interventions for improving communication with children and adolescents about their cancer. They concluded from 10 studies that weak evidence exists to suggest that some children and adolescents may derive some benefit from specific information-giving programmes and from interventions that aim to facilitate their reintegration in school and social activities. The interventions were directed towards communication generally rather than communication directed towards decision-making. O'Connor 2009 updated their 2003 review of decision aids for people facing health treatment or screening decisions. They concluded from 25 new studies that decision aids improve knowledge and realistic expectations, enhance active participation in decision-making, lower decisional conflict, decrease the proportion of people remaining undecided, and improve agreement between values and choices. Although this review showed that decision aids can assist in promoting decision-making, none of the studies included interventions for children with cancer.
Description of the intervention
Any intervention for SDM for children with cancer. The interventions should focus primarily on children, but can also include carers, parents and health providers. The term 'parent' refers to a parent or the person or guardian serving in the parental role. For convenience, we will use the term 'parent' in all circumstances.
Defining shared decision-making (SDM)
Although significant conceptual work has taken place to define SDM many inconsistent definitions currently exist, which means that the concept is open to different interpretations (Makoul 2006) . One conceptual framework has identified the core aspects of SDM (Charles 1997; Charles 1999) . Drawing on this work, SDM is defined as having four necessary characteristics.
1. SDM involves at least two participants, the healthcare professional and child, and can involve three: healthcare professional, parent and child.
2. Both the healthcare professional and child share information with each other.
3. Both the healthcare professional and child take steps to participate in the treatment decision-making process by expressing treatment preferences.
4. A treatment decision is made and both the healthcare professional and child agree to the decision.
How the intervention might work
Interventions used to help children make shared decisions may consist of those aimed at improving information exchange, understanding, and communication; and those aimed at encouraging children to participate in decision-making. The interventions may aim to enhance children's abilities to participate in SDM, or they might be interventions targeted at healthcare professionals or parents, or both, to encourage them to include children with cancer in the decision-making process. For example, some interventions may help children to understand options and consequences while others may focus on developing children's skills. Other interventions may focus on educating parents and healthcare professionals and improving their motivation and skills to support children's participation. 
Why it is important to do this review

O B J E C T I V E S
To examine the effects of SDM interventions on the process of SDM for children with cancer who are aged four to 18 years.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) of SDM interventions with children with cancer. We excluded cross-over trials as this design is not appropriate when an intervention can have a lasting effect that compromises entry to subsequent periods of the trial.
Types of participants
For the purpose of this review, a child is defined as a person between four and 18 years of age. Children younger than four years were excluded as they are potentially too young to participate in the interventions adequately.
1. Children diagnosed with any type or stage of cancer; studies with children diagnosed with cancer who also have other illnesses were eligible.
2. Studies that involved parents or healthcare professionals, or both were eligible.
3. Studies that involved interventions given to only one group (for example children or parents or healthcare professionals), a combination of two groups (for example parents and children or healthcare professionals and children), or all three groups of participants (children, parents, and healthcare professionals) were eligible. The term 'healthcare professionals' refers to doctors and nurses and, for this review, excludes any other healthcare professional.
Types of interventions
Studies evaluating an intervention designed to promote SDM between children with cancer and parents and healthcare professionals were eligible for inclusion. The types of decisions included decisions faced in the context of clinical care, such as treatment decisions, healthcare decisions, and research participation decisions. Studies focused on the involvement of children in consent or assent for involvement in clinical trials were eligible for inclusion. SDM interventions developed for research participation were relevant for this review. At the same time, it must be noted that research participation decisions and treatment decisions differ in fundamental ways that may have substantial effects on information provision, competence to process the information, and the capacity to respond voluntarily to the options available. Decisions about research participation could result in different outcomes as compared to treatment decisions. Therefore, a subgroup analysis was planned if sufficient studies were found to compare research decisions with clinical care decisions, but since no eligible studies were identified, this was not feasible. Interventions presented individually or in group sessions were eligible for inclusion. Examples of interventions could include the following:
• providing information to a child, parent, or healthcare provider, or combinations of the three (communication interventions such as: booklet, video, web resources, workbook, posters, meetings, role play, puppets);
• preparing the child or parent, or both, to participate in decision-making (educational interventions such as specific educational programmes, memory prompts, pre-consultation rehearsal questions, question prompt sheets, decision aids or boards, online decision support tutorials, leaflets, posters, media, implementation of models of participation, guidelines);
• training interventions targeted at healthcare professionals to promote implementation of SDM;
• providing opportunities to review decisions made. . The diversity of instruments available for measuring SDM demonstrates the broad range of constructs involved in its assessment (Dy 2007) . The primary outcome of SDM is often measured through direct observation of the behaviour exhibited by physician, parents, and patient.
Types of outcome measures
• Patient's and parents' behavioural outcomes (for example patterns of interaction with the medical care team, development of communication skills or techniques, level of involvement, question asking) could have been measured with scales such as: the Child Behaviour Checklist (CBCL) (Achenbach 1991), Perceived Involvement in Care Scale (Lerman 1990) , and the Autonomy Preference Index (Ende 1989).
• Health professionals' behavioural outcomes (for example patterns of communication, patient-directed questions, amount of deliberation, and time spent) could have been measured by scales such as: the Roter Interaction Analysis System (RIAS) (Roter 1991) and the DCS (O'Connor 1995).
The second primary outcome was measures of adverse effects.
• Anxiety (Spielberger 1973) or uncertainty (O'Connor 1995), or both.
Secondary outcomes
If the primary outcome of interest was met then the secondary outcomes were:
• Measures of decisional quality (for example whether the patient or parent was adequately informed about the options, pros and cons discussed, preferences met, understanding checked, decisional conflict reduced). Scales that could have been included were the Satisfaction with Decision Scale (Holmes-Rovner 1996), Decisional Quality Inventory (DMQI) (Hollen 1999), and DCS (O'Connor 1995).
• Measures of patient psychological outcomes (for example self concept, sense of control, satisfaction, stress, anxiety). Scales such as the STAIC scale for children (Spielberger 1973 
Search methods for identification of studies
See: Cochrane Childhood Cancer Group methods used in reviews (Kremer 2010). We did not impose language restrictions.
Electronic searches
We searched the following sources: Cochrane Central Register of Controlled Trials (CENTRAL), The Cochrane Library, Issue 9, (2012) 
Data collection and analysis
Selection of studies
We used the following process for selecting RCTs of SDM interventions for children with cancer.
1. We merged search results using reference management software (Endnote) and removed duplicate records of the same report.
2. We examined titles and abstracts to remove obviously irrelevant reports, and were over-inclusive at this stage to ensure relevant reports were not accidentally removed.
3. The remaining abstracts (or an extract) were examined by two review authors and independently screened for applicability according to the following criteria: randomised trial, intervention, children aged four to 18 years, parents, healthcare professionals, and outcomes.
4. A third review author resolved any disagreements regarding selection of relevant studies and for full-text articles.
5. We retrieved full text of the potentially relevant reports. 6. We linked multiple reports of the same study using the criteria detailed in Section 7.2.2 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).
7. We examined full-text reports for compliance of studies with eligibility criteria.
8. We corresponded with investigators where appropriate to clarify study eligibility and to request missing data where necessary.
9. We did not find any studies that met the inclusion criteria for this review so we could not proceed to data extraction.
Data extraction and management
Since we found no eligible studies for inclusion in this review, data extraction by two independent review authors using a standardised form could not be performed.
Assessment of risk of bias in included studies
Since we found no eligible studies for inclusion in this review, risk of bias assessment using the latest criteria of the Childhood Cancer Group was not applicable.
Data synthesis
Since we found no eligible studies for inclusion in this review, data analyses could not be performed.
R E S U L T S Description of studies
Results of the search
The review authors identified 5364 potentially relevant documents from only the electronic databases, of which 5359 were excluded by reviewing titles and abstracts. Of the remainder, we retrieved four full publications for more detailed screening (Beale 2007; Dragone 2002; Jones 2010; Kato 2008) . Following full scrutiny of the full-text articles that reported the four studies, none of these studies measured the primary outcome of SDM, and hence no eligible studies for inclusion in this review were identified. The electronic search of the databases (EMBASE) yielded one abstract that was presented at the World Congress of Psychology conference in October 2011. The author was contacted and kindly sent us a copy of the abstract that was published (Kurt 2011). The author confirmed that the study was part of a doctorate thesis that has not been published as yet. The author confirmed that the study did not measure the primary outcome of SDM. Three reviews were found from the electronic database search and we had copies of those already. These were : Joosten 2008; Ranmal 2008; and Scott 2003 . No eligible studies were identified while screening the reference lists of these reviews. The other searches did not yield any eligible studies for inclusion in this review.
Included studies
No eligible studies for inclusion in this review were identified.
Excluded studies
Two of the excluded papers were from the same study, which was a multi-site RCT of a psycho-educational intervention with adolescent and young adults with cancer (aged 13-29 years) (Beale 2007; Kato 2008) . The psycho-educational intervention was a video game called 'Re-Mission', which was compared with a regular commercial game. One paper reported on the effect of the video game (Re-Mission) on cancer-related knowledge (Beale 2007). The other paper from the same study reported on treatment adherence (primary outcome) and cancer-related knowledge, cancerspecific self efficacy, and quality of life, stress, and control (secondary outcomes). We excluded these studies because they did not include SDM as an outcome. The excluded abstract by Kurt 2011 reported an RCT of ReMission compared with a regular commercial game in adolescents and young adults with cancer (aged 13-18 years). The purpose was to determine the effectiveness of a video game intervention for improving emotional and behavioural outcomes. We excluded this study because they did not include SDM as an outcome. Two studies evaluated computer-based information programs. One compared an interactive CD-ROM product (Kidz with Leukaemia: A Space Adventure) with a book by Lynn Baker for children aged four to 11 years with leukaemia and their parents (Dragone 2002). The outcomes measured were the children's health locus of control, understanding of leukaemia, and satisfaction with the intervention. The other study compared a CD-ROM designed to teach 12 to 18 year old people with solid tumours about their disease, treatment, coping skills, and late effects with a handbook (Jones 2010). We excluded these studies because they did not include SDM as an outcome. See also the Characteristics of excluded studies table.
Risk of bias in included studies
Effects of interventions
Since we found no eligible studies for inclusion in this review, it was not possible to examine the effects of interventions to promote SDM for children with cancer who are aged four to 18 years.
D I S C U S S I O N
Unfortunately we did not find any eligible studies for inclusion in this review. The five studies that came closest to meeting the inclusion criteria of this review reported outcomes that could impact on the process of SDM through a variety of mechanisms (Beale 2007; Dragone 2002; Jones 2010; Kato 2008; Kurt 2011) . The outcomes were: understanding, cancer-related knowledge, self efficacy, stress, and internal locus of control. Improving understanding through information exchange and communication may encourage children to participate in decision-making. Reduction in stress may help children to absorb information more easily thus enabling them to become more involved in discussions about decisions (McCabe 1996) . It is hypothesised that educational interventions that help support or enhance children's internal locus of control or health locus of control may encourage children to participate in decision-making. Perceived control over one's health can influence feelings of self -efficacy (Bandura 1977). Self efficacy can both affect and be affected by information and communication (Makoul 1998) . Therefore interventions that enhance children's feelings of self efficacy may help children to feel more confident to seek information and become involved in decision-making. Likewise involvement in decisions may enhance self efficacy (Miller 2012; White 1996) .
It is clear that information exchange is a pre-requisite for participation in decision-making (Makoul 2006) . Improvements to routine communications between child-parent-healthcare professional coupled with communication interventions may help children with cancer to participate in SDM in several ways. It may help children to understand their disease and treatment better so that with more knowledge they are enabled to offer their views (Hokkanen 2004) . Improvement in communication interactions may help children to become more familiar with healthcare professionals and to develop relationships with them. Having a good relationship with healthcare professionals may encourage children to participate in communication interactions (Dunsmore 1995) . Feeling more prepared and comfortable interacting with healthcare professionals may encourage children to seek inclusion in the decision-making process, to ask more questions and express their preferences (Leveton 2008; Zwaanswijk 2007) . However, Ranmal 2008 updated a review of interventions to improve communication with children and adolescents about their cancer and found that interventions to enhance communication have not been widely or rigorously assessed. They found studies that used the following interventions: computer-assisted education programme, CD-Rom about leukaemia, art therapy, group therapy, play and story-telling, and a self care coping intervention. They described the evidence as weak and recommended more research into the effects of these interventions and other related interventions. Interventions are needed both to improve communication and participation in decision-making.
Légaré 2010 reviewed the interventions for improving the adoption of SDM by healthcare professionals and concluded that the evidence was sparse and weak. They could not draw firm conclusions about the most effective types of interventions for increasing healthcare professionals' adoption of SDM. They suggested that educational meetings, giving healthcare professionals feedback or learning materials (or both), and using patient decision aids are some interventions that might be helpful. Educational interventions that may increase healthcare professionals' awareness of children's need for inclusion in decisions could be useful. Légaré 2010 pointed out that implementation studies of SDM in clinical practice are increasing each year. Thus it is likely that there will be an increase in interventions that encourage healthcare professionals to adopt SDM. We did not find any interventions on SDM for healthcare professionals working in the area of childhood cancer, so more research is needed in this area.
In an update of the O'Connor 2009 review of decision aids for adults facing health treatment or screening decisions, Stacey 2012 found that decision aids combined with values clarification exercises improve knowledge of options, has a positive effect on patient-practitioner communication, and stimulates people to participate more in decision-making. Stacey 2012 included studies involving people who were making decisions about screening or treatment options for themselves, for a child, or for an incapacitated significant other. None of the studies included interventions for parents of children with cancer or for children with cancer. But this review is very relevant as it showed that decision-aids stimulate adults and parents to participate more in the decisionmaking process. Therefore good-quality decision aids developed and tailored for children with cancer could be useful interventions to support children's efforts to participate in SDM. Decision aids that are developed in childhood cancer need to adhere to the IPDAS Collaboration quality criteria on choice and the decision process (Elwyn 2006; O'Connor 2005) . This review also suggests the need to assess children's preferences for how they want to be involved in the decision-making process. The control preferences scale (Degner 1992) could be adapted and used to assess how children prefer to be involved in SDM. Joosten 2008 suggests that SDM can be an effective and useful way of reaching a treatment decision when people have to make long-term decisions. SDM can be complex, therefore SDM in chronic childhood illness may be easier as there are more chances to deliberate over decisions or to revisit decisions. In childhood cancer the treatment trajectory is complex and lengthy, therefore, efforts to include children in SDM may help children cope better with the illness. In conclusion, more high-quality research is needed in order to answer the questions of the review. SDM is a process in which children, parents, and healthcare professionals share information, express treatment preferences, and agree to the decision made. Children with cancer generally prefer to be involved in SDM and consider it important that they have the opportunity to take part in healthcare decision-making (Stegenga 2008; Zwaanswijk 2011) and sometimes in end-of-life decisions (Hinds 2005) . Children prefer a collaborative role in that they want to be involved, consulted but not necessarily to have full responsibility for the decision made (Coyne 2011). Children should be involved as much as possible in decisions about their care, even when they are not able to make decisions on their own (Wood 2010) . This concurs with current guidelines in paediatric oncology, which advocate that healthcare professionals encourage children to participate in medical decisions according to their developmental level (Spinetta 2003) .
However, it is important to note that much of the evidence promoting children's participation is authored by policy makers and that we lack strong evidence from research that supports these recommendations. It does seem to be the 'right' approach for clinicians to include children in SDM but we do not have strong evidence that indicates which children desire inclusion, at what point in the trajectory of their treatment or illness, and with whom do they want to share decision-making and about what topic. Children sometimes prefer a passive role in SDM because they are too ill or distressed by the treatments. Likewise some children prefer to hear information from their parents especially if it is 'bad' news or about treatment side effects (Coyne 2010). Decision-making in childhood cancer can be challenging (Whitney 2006) and parents are usually the main decision-makers (Pyke 2006) and strongly influence whether their child is involved or allowed to participate in SDM (Coyne 2010). The actual sequencing to how parent-childprofessional participate in SDM is still not adequately described in any of the current research studies so there is a need for much more research in this area. It is important that children and parents are not seen as one actor as children's position in decision-making could be undermined (Andre 2004). We need interventions that help support children's participation in SDM but which will also recognise and maintain family integrity. The limited evidence on parents' perceptions of proxy decision-making indicates that parents find it challenging for many reasons (Jackson 2008; Young 2010) . Perhaps the focus should be towards developing interventions targeted at parents and children so that parents can promote and support their child's participation in SDM. 
A U T H O R S ' C O N C L U S I O N S Implications for practice
Implications for research
More research in needed to investigate the effects of interventions that promote participation in SDM for children with cancer. New studies should be RCTs. Identifying such interventions will provide reassurance and guidance, and potentially contribute to successful communication between children, parents, and the healthcare team. The interventions should be developed with the support of children and also should draw upon existing research, which reports the needs and preferences of children with cancer about SDM (Coyne 2010; Stegenga 2008) . Research on SDM for children with other chronic illnesses may add useful information (Coyne 2011; Miller 2012) . Tailoring the interventions to children's preferences may help make the intervention more acceptable to children with cancer. SDM for children with cancer should be promoted as a positive end in itself rather than a means to achieve other ends desired by healthcare staff such as patient compliance.
Including children in healthcare SDM is an area that is relatively under-researched and underdeveloped but over time we should see more research occurring. Advances in technology will potentially lead to more developments of multimedia interventions to promote communication and SDM for children with chronic illnesses. A large number of patient decision aids has been developed for adult patients (Stacey 2012) and similar work needs to be done for children and young people. Studies are needed into how new multimedia innovations can support information exchange between children and healthcare professionals. Children are more familiar with new technologies and may prefer to receive information about their disease and treatments via an information technology medium (Suris 2010).
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C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of excluded studies [ordered by study ID]
Study
Reason for exclusion (SU.EXACT.EXPLODE("African American Children" OR "Children" OR "Grandchildren" OR "Hospitalized Children" OR "Latchkey Children" OR "Migrant Children" OR "Minority Group Children" OR "Preadolescents" OR "Young Children") OR SU. 
